Insulin Glargine Pen Injector [Lantus]
Sponsors
Indonesia University
Conditions
Diabetes Mellitus
Phase 2
Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients
CompletedNCT03352674
Start: 2016-09-30End: 2018-12-01Updated: 2020-04-01
The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus
NCT04591457
Start: 2020-10-31End: 2021-08-31Target: 120Updated: 2020-10-19